Nathan Sweeney, PhD (@nsweeneyphd) 's Twitter Profile
Nathan Sweeney, PhD

@nsweeneyphd

Cancer Biologist

Catharanthus roseus (periwinkle) - extract from this led to the development of vincristine, a powerful chemotherapy drug. Credit: @melissapher

ID: 1466843917328871425

calendar_today03-12-2021 18:57:23

18 Tweet

23 Followers

35 Following

Nathan Sweeney, PhD (@nsweeneyphd) 's Twitter Profile Photo

HealthTree Cure Hub: A Patient-Derived, Patient-Driven Clinical Cancer Information Platform Used to Overcome Hurdles and Accelerate Research in Multiple Myeloma DOI: 10.1200/CCI.21.00141 Mike Thompson, MD, PhD, FASCO Faith E Davies Jennifer Ahlstrom HealthTree Foundation JCO Clinical Cancer Informatics #MultipleMyeloma

HealthTree Cure Hub: A Patient-Derived, Patient-Driven Clinical Cancer Information Platform Used to Overcome Hurdles and Accelerate Research in Multiple Myeloma
DOI: 10.1200/CCI.21.00141

<a href="/mtmdphd/">Mike Thompson, MD, PhD, FASCO</a> <a href="/FaithEDavies1/">Faith E Davies</a> <a href="/AhlstromJenny/">Jennifer Ahlstrom</a> <a href="/HealthTree/">HealthTree Foundation</a> <a href="/JCOCCI_ASCO/">JCO Clinical Cancer Informatics</a> #MultipleMyeloma
JCO Clinical Cancer Informatics (@jcocci_asco) 's Twitter Profile Photo

.HealthTree Foundation showcases how #RealWorldData research with the most complete & valid #MultipleMyeloma patient data set can accelarate research, develop hypothesis and improve survival in multiple myeloma. fal.cn/3n9iw Nathan Sweeney, PhD Mike Thompson, MD, PhD, FASCO #JCOCCI #AI

.<a href="/HealthTree/">HealthTree Foundation</a> showcases how #RealWorldData research with the most complete &amp; valid #MultipleMyeloma patient data set can accelarate research, develop hypothesis and improve survival in multiple myeloma. fal.cn/3n9iw <a href="/NSweeneyPhd/">Nathan Sweeney, PhD</a> <a href="/mtmdphd/">Mike Thompson, MD, PhD, FASCO</a> #JCOCCI #AI
Nathan Sweeney, PhD (@nsweeneyphd) 's Twitter Profile Photo

..Next, we found SMM patients who do not receive early intervention with treatment develop MM 2x faster than those who do receive early intervention with treatment, regardless of progression risk level (n = 129, p-value < 0.001). meetings.asco.org/abstracts-pres… #ASCO22 #Healthtree #MMSM

Nathan Sweeney, PhD (@nsweeneyphd) 's Twitter Profile Photo

While there is strong evidence of health disparities our findings revealed that where one lives geographically is not a probable reason why non-Whites experience delays in care, are under-treated or lack access to MM specialists. meetings.asco.org/abstracts-pres… #mmsm #ASCO22 #Healthtree

Nathan Sweeney, PhD (@nsweeneyphd) 's Twitter Profile Photo

Our results highlight that drug toxicity and being on treatment profoundly impacts patient's perception of cure. meetings.asco.org/abstracts-pres… Manni Mohyuddin @MyelomaSLC @MyelomaTeacher - Cindy Chmielewski #ASCO22 #healthtree #mmsm

Manni Mohyuddin (@mannimd1) 's Twitter Profile Photo

Our work on how patients perceive cure in myeloma: -they prioritize being off treatment and account for toxicity of treatment more than we do when we think of cure - they remain unaware of terms such as functional cure #mmsm #asco22

Our work on how patients perceive cure in myeloma:

-they prioritize being off treatment and account for toxicity of treatment more than we do when we think of cure

- they remain unaware of terms such as functional cure

#mmsm #asco22
Valarie Traynham (@myelomavalarie) 's Twitter Profile Photo

The virtual 5K/1mile event is just days away. We've reached a little over 21% of the $50,000 goal. Continue to spread the word & encourage your friends & family to join you. 100% of the proceeds raised will support the Black Myeloma Health Initiative. #myeloma #blackmyelomahealth

The virtual 5K/1mile event is just days away. We've reached a little over 21% of the $50,000 goal. Continue to spread the word &amp; encourage your friends &amp; family to join you. 100% of the proceeds raised will support the Black Myeloma Health Initiative.
#myeloma #blackmyelomahealth
Nathan Sweeney, PhD (@nsweeneyphd) 's Twitter Profile Photo

Age-associated decline may be avoided or reversed with regular exercise and minimizing sedentary time. Read more here: myelomacrowd.org/myeloma/commun… #healthtree #mmsm @healthtreeforMM

Nathan Sweeney, PhD (@nsweeneyphd) 's Twitter Profile Photo

Quad vs Tri Induction Therapy in Multiple Myeloma. A Retrospective Comparison of the Side Effect & Severity. The addition of a 4th drug did not affect the severity or, on a whole, the prevalence of the SE experienced by pts. ash.confex.com/ash/2022/webpr… #MMSM #ASH22 @HealthTreeMM

Quad vs Tri Induction Therapy in Multiple Myeloma. A Retrospective Comparison of the Side Effect &amp; Severity.

The addition of a 4th drug did not affect the severity or, on a whole, the prevalence of the SE experienced by pts.
ash.confex.com/ash/2022/webpr…

#MMSM #ASH22 @HealthTreeMM
Nathan Sweeney, PhD (@nsweeneyphd) 's Twitter Profile Photo

MM Patient's Top Concerns At and Since Diagnosis. Squint and read the poster or watch the video brought to you by @HealthTreeU youtu.be/-VVxpqmR45M #ASH22 #mmsm

MM Patient's Top Concerns At and Since Diagnosis. Squint and read the poster or watch the video brought to you by @HealthTreeU 

youtu.be/-VVxpqmR45M

#ASH22 #mmsm
Nathan Sweeney, PhD (@nsweeneyphd) 's Twitter Profile Photo

MM quad v. tri therapies: SE and severities. Read the poster or watch the video (youtu.be/JTqQCn2FHiI) @HealthTreeU #mmsm #ASH22

MM quad v. tri therapies: SE and severities. Read the poster or watch the video (youtu.be/JTqQCn2FHiI)

@HealthTreeU #mmsm #ASH22